Skip to content

From lab-bench to bedside
Clinical trials

Clinical trials are a key step in the development of new treatment options, and they allow patients to get access to innovative therapies before marketing authorization.

Starting points for trials can either be promising research results from the lab, cell culture and pre-clinical models or the re-purposing of, for other indications already authorized, medicines. In both cases, a careful evaluation of relevance, feasibility and safety for the new patient cohort is essential. With their participation in clinical trials, patients become an essential part in drug development.

Depending on the scale and phase of the trial and available resources, several kinds of studies are conceivable. Study centres can conduct an academic trial themselves or out-license the trial to a specialized company. Furthermore, pharma companies often approach clinics with their request for participation in sponsored trials. The study protocol (detailed treatment and analyses plan of the trial) should be developed in close cooperation with competent authorities, ethics committees, patient advocacies and the pharma industry.

Get to know more about the purpose and procedure of a clinical trial, as well as about the roles of the different players involved.

Get to know more

Detailed information about ongoing clinical trials worldwide are listed in public databases which you can find here.

Ongoing clinical trials
Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .